0000899243-18-014245.txt : 20180529 0000899243-18-014245.hdr.sgml : 20180529 20180529160553 ACCESSION NUMBER: 0000899243-18-014245 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180524 FILED AS OF DATE: 20180529 DATE AS OF CHANGE: 20180529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BlueMountain Capital Management, LLC CENTRAL INDEX KEY: 0001427430 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37887 FILM NUMBER: 18864453 BUSINESS ADDRESS: STREET 1: 280 PARK AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 905-3900 MAIL ADDRESS: STREET 1: 280 PARK AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MedEquities Realty Trust, Inc. CENTRAL INDEX KEY: 0001616314 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 465477146 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3100 WEST END AVENUE STREET 2: SUITE 1000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: (615) 324-7822 MAIL ADDRESS: STREET 1: 3100 WEST END AVENUE STREET 2: SUITE 1000 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-24 0 0001616314 MedEquities Realty Trust, Inc. MRT 0001427430 BlueMountain Capital Management, LLC 280 PARK AVENUE, 12TH FLOOR NEW YORK NY 10017 1 0 0 0 Common Stock 2018-05-24 4 S 0 10000 10.32 D 2219047 I Footnotes Common Stock 2018-05-24 4 S 0 2020 10.38 D 2217027 I Footnotes Common Stock 2018-05-25 4 S 0 10000 10.34 D 2207027 I Footnotes Common Stock 2018-05-25 4 S 0 1401 10.40 D 2205626 I Footnotes The filing of this Form 4 shall not be construed as an admission that BlueMountain Capital Management, LLC ("BMCM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any of the shares of Common Stock, par value $0.01 per share (the "Common Stock"), of MedEquities Realty Trust, Inc. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, BMCM disclaims such beneficial ownership, except to the extent of its pecuniary interest. BMCM is the investment manager of Blue Mountain Credit Alternatives Master Fund L.P., BlueMountain Guadalupe Peak Fund L.P. ("Guadalupe"), BlueMountain Credit Opportunities Master Fund I L.P., BlueMountain Strategic Credit Master Fund L.P. ("Strategic") and BlueMountain Montenvers Master Fund SCA SICAV-SIF (collectively, the "Funds"), which are the direct beneficial owners of 2,205,626 shares of Common Stock in the aggregate. BMCM, although it directs the voting and disposition of the Common Stock held by the Funds, only receives an asset-based fee relating to the Common Stock held by the Funds. On May 24, 2018, Guadalupe sold 3,740 and 756 shares of Common Stock for $10.32 and $10.38 per share, respectively, and Strategic sold 6,260 and 1,264 shares of Common Stock for $10.32 and $10.38 per share, respectively. On May 25, 2018, Guadalupe sold 3,740 and 524 shares of Common Stock for $10.34 and $10.40 per share, respectively, and Strategic sold 6,260 and 877 shares of Common Stock for $10.34 and $10.40 per share, respectively. Elliot Mandelbaum, a former employee of BMCM, serves as a member of the board of directors of the Issuer as the representative of BMCM. In connection therewith, BMCM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, BMCM is listed a "Reporting Person" in Item 1 and the "Director" box is marked in Item 5 of this Form 4. BlueMountain Capital Management, LLC, By: /s/ Eric M. Albert, Chief Compliance Officer 2018-05-29